The 2023 Influenza Vaccine Production & Distribution Market Report provides insights into both the previous and current flu seasons, vaccine makeup and effectiveness, and the overall decline in vaccine coverage in the U.S.

Key Insights
  • Doses distributed: 173.4 million doses of the influenza vaccine were distributed during the 2022–2023 flu season.
  • Vaccine effectiveness: A 54% vaccine effectiveness was estimated for the 2022–2023 flu season, the highest since 2013.
  • Adult vaccination rate: 46.9% of U.S. adults received their influenza vaccine in the 2022–2023 flu season.

Members can access a single-license download of the full report via the Member Download button. Organization-wide PDF licenses and single-license downloads can be purchased below.

Member Download

 
Picture of the productInfluenza Vaccine Market Report: Organization License
**Organization-Wide PDF License**

Price (Members and Non-Members): $1,550

Regular price: 1,550.00
Quantity   

 
MR2304LICENSE
Picture of the productInfluenza Vaccine Market Report: Single License
**Single License**

Members: Complimentary
Non-Members: $50

Regular price: 50.00
Discounted member price: 0.00
Quantity   

 
MR2304SINGLE

My Cart

Items

There are no records.

 
 

Contact:

Chandler Mobley

Chandler Mobley, MPH
Manager, Research & Market Insights
703-838-6113
mobley@hida.org